114326-12-4

Basic information

• Product Name: Carbamic acid, [3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]propyl]-, 1,1-dimethylethyl ester
• CAS NO: 114326-12-4
• Molecular Formula: C14H31NO3Si
• Molecular Weight: 289.491
• Mol File: 114326-12-4.mol
• Article Data: 11

Chemical Properties

• CAS DataBase Reference: Carbamic acid, [3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]propyl]-, 1,1-dimethylethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, [3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]propyl]-, 1,1-dimethylethyl ester(114326-12-4)
• EPA Substance Registry System: Carbamic acid, [3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]propyl]-, 1,1-dimethylethyl ester(114326-12-4)

Safety Data

• Hazardous Substances Data: 114326-12-4(Hazardous Substances Data)

Upstream product

• 58885-58-8 N-tert-butoxycarbonyl-3-aminopropanol 
• 18162-48-6 tert-butyldimethylsilyl chloride 

Downstream Products

• 58885-58-8 N-tert-butoxycarbonyl-3-aminopropanol 
• 1181285-69-7 tert-Butyl 3-(4-(dimethylamino)-4-phenylpiperidin-1-yl)propyl(methyl)-carbamate 
• 169220-12-6 (E)-(R)-methyl 3-<2-ethyl>-4-hexenoate 
• 169129-36-6 methyl (Z)-3-<2-ethyl>-4-hexenoate 
• 169129-45-7 (E)-(R)-6--3-hexen-2-ol 
• 169129-35-5 (E)-methyl N-benzyl-N-tert-butoxycarbonyl-5-amino-2-pentenoate 
• 98014-76-7 3-[N-benzyl-N-(tert-butoxycarbonyl)amino]propan-1-ol 
• 169129-44-6 (E)-6-[N-benzyl-N-(tert-butoxycarbonyl)amino]-3-hexen-2-one 
• 98014-77-8 3-(N-benzyl-N-tert-butoxycarbonylamino)propanal 
• 433925-63-4 3-[(tert-butoxycarbonyl)amino]propyl acetate 
• 114325-83-6 Methyl-[3-(2-oxo-2-phenyl-ethylsulfanyl)-propyl]-carbamic acid tert-butyl ester 
• 114326-14-6 N-(tert-butoxycarbonyl)-N-methyl-3-chloropropylamine 
• 98642-44-5 tert-butyl (3-hydroxypropyl)methylcarbamate 

Relevant articles and documents

Benzil compound as well as preparation method and application thereof

The invention provides a benzil compound as well as a preparation method and application thereof, the structure of the benzil compound is shown as a formula I, wherein R1 is -(CH2) n-N (CX1Y1Z1) (CX2Y2Z2), n is an integer from 1 to 6, and X1, X2, Y1, Y2, Z1 and Z2 are independently selected from hydrogen or deuterium. The benzil compound provided by the invention is applied to detection of guanidine compounds, can remarkably improve the sensitivity, accuracy and stability of detection, can be used for identifying potential guanidine compounds in a to-be-detected sample, and is low in cost.

Method for producing polyalkylene glycol derivative having amino group at end, polymerization initiator for use in the same, and alcohol compound as raw material for the polymerization initiator

A method for producing a narrowly distributed and high-purity polyalkylene glycol derivative having an amino group at an end, a polymerization initiator for use in the method, and a precursor of the polymerization initiator are provided. The present invention provides: a method for producing a polyalkylene glycol derivative having an amino group at an end, using, as a polymerization initiator, a compound represented by the general formula (I); a compound represented by the following general formula (I); and a precursor thereof: wherein RA1a and RA1b each independently represent a protective group of the amino group, or one of RA1a and RA1b represents H and the other represents a protective group of the amino group, or RA1a and RA1b bind to each other to represent a cyclic protective group forming a ring; RA2 represents a linear, branched, or cyclic hydrocarbon group having 1 to 6 carbon atoms; RA3 represents a single bond, or a linear, branched, or cyclic hydrocarbon group having 1 to 20 carbon atoms, and the hydrocarbon group may contain a heteroatom; the total number of carbon atoms (or the total number of carbon atoms and heteroatoms) of RA2 and RA3 is 4 or more; and M represents an alkali metal.

Substituted Indole Compounds

Substituted indole compounds corresponding to the formula I: In which R8, R9a, R9b, R10, R11, R200, R210, A, D, T, q, s and t have defined meanings, processes for the preparation thereof, pharmaceutical compositions containing such compounds and the use of substituted indole compounds for the treatment or inhibition of pain and other conditions which are at least partly mediated by Bradykinin 1 receptors (B1R).